OK. I think we are talking about two different things. I'm not criticizing if NP has the RIGHT to feel upset at the question. Because as you explained, there has been a lot of harping on the Dr. BP thing. Just speaking for myself as an investor holding a significant (for me) position in CYDY, I prefer a CEO who who is better able to control his emotions during an investor conference call.
And for the record, I don't feel using the Dr. BP LH Index would be a good idea either. It's too new. It would have to be vetted and accepted by the FDA and scientific community before it would have any useful application in the trial that would need to get started asap since we have so many people suffering today.